Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement [Phase 2]
Phase 2 clinical trial update for rituximab in people with psychosis and obsessive-compulsive disorder with suspected immune involvement; re…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Effects of tES Combined With Retrieval Practice on Semantic Memory in Patients With Schizophrenia [NA]
Completed clinical study evaluating transcranial electrical stimulation combined with retrieval practice for improving semantic memory in pa…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Service User and Staff Views on Digital Remote Monitoring for Psychosis
A completed clinical trial update reporting on the views of service users and staff regarding digital remote monitoring for psychosis.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia [NA]
This update reports a completed clinical trial evaluating a mobile-assisted cognitive behavioral therapy intervention for negative symptoms …
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Mobile CBT for Negative Symptoms [NA]
A completed clinical trial evaluating mobile cognitive-behavioral therapy for negative symptoms in schizophrenia and schizoaffective disorde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Lumateperone for the Prevention of Relapse in Patients With Schizophrenia [Phase 3]
A Phase 3 trial evaluating lumateperone for relapse prevention in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment [Phase 4]
Phase 4 trial comparing remimazolam and etomidate as induction agents for electroconvulsive therapy has completed, potentially informing ane…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of ASP4345 in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia [Phase 1]
This clinical trial update summarizes a Phase 1 study of ASP6981 in schizophrenia, evaluating safety, tolerability, pharmacodynamics, and ph…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia [Phase 3]
This is a Phase 3 long-term, once-weekly brexpiprazole trial in schizophrenia that is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia [Phase 3]
This update describes a completed Phase 3 study evaluating the safety, tolerability, and treatment response of paliperidone palmitate in sch…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) [Phase 3]
Extension study EMERGENT-4 evaluated long-term safety, tolerability, and efficacy of KarXT in adults with schizophrenia; results from this P…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia [Phase 4]
Phase 4 clinical trial completed evaluating the effectiveness and safety of paliperidone palmitate in adults with acute schizophrenia.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 [Phase 3]
Phase 3 study evaluating pharmacokinetics and safety/tolerability of Long-Acting Oral LYN-005 in schizophrenia and schizoaffective disorder …
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia [NA]
The NST-SPARK trial reports completion of a preliminary study evaluating an augmented reality app delivering recovery-oriented cognitive the…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia [NA]
This update reports results from a completed clinical trial evaluating the efficacy of an early antipsychotic switch in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses [NA]
The clinical trial 'Opening Doors to Recovery' for persons with serious mental illnesses has completed and posted results, sponsored by the …
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia [Phase 2, Phase 3]
This update reports results from a Phase 2/3 trial evaluating adjunctive Ashwagandha (Withania somnifera) for persistent symptoms in schizop…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: CVN058 Effect on Mismatch Negativity in Schizophrenics [Phase 1]
Phase 1 trial evaluating CVN058 on mismatch negativity in individuals with schizophrenia; the study has completed and results were posted on…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011) [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of MK-8189 in participants with schizophrenia and in healthy volunteers; …
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Investigating the Cognitive Source of Visual Working Memory Impairment in Schizophrenia [NA]
A completed clinical trial evaluating a neurostimulator approach for visual working memory impairment in schizophrenia; no efficacy results …
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 [Phase 3]
Phase 3 clinical trial update for ALKS 3831 reporting long-term safety, tolerability, and durability of treatment effect; results have been …
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Cigarette Smoking in Smokers With and Without Schizophrenia [NA]
A completed clinical trial compared cigarette smoking in smokers with schizophrenia to those without schizophrenia; results have been posted…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Accelerated rTMS for Psychomotor Slowing [NA]
A University of Bern-sponsored clinical trial evaluating accelerated rTMS for psychomotor slowing in schizophrenia-related disorders has bee…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Aspirin in Young Psychotic Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating aspirin in young patients with psychosis has completed and results have been posted.